Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Vitamin D3 in Pancreatic Cancer Surgery
NCT03472833Phase 3Terminated
- Sponsor
- Medical University of Graz
- Start
- Apr 2018
- Primary completion
- Apr 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by Medical University of Graz. Primary endpoint: 25(OH) vitamin D at Day 60. Started Apr 2018; status: terminated.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03472833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03472833.